BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9788562)

  • 1. Fragile X founder effects in Argentina.
    Bonaventure G; Torrado M; Barreiro C; Chertkoff L
    Am J Med Genet; 1998 Sep; 79(3):200-4. PubMed ID: 9788562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DXS548/FRAXAC1 haplotypes in fragile X chromosomes in the Brazilian population.
    Mingroni-Netto RC; Costa SS; Angeli CB; Vianna-Morgante AM
    Am J Med Genet; 1999 May; 84(3):204-7. PubMed ID: 10331592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FMR1 haplotype analyses among Indians: a weak founder effect and other findings.
    Sharma D; Gupta M; Thelma BK
    Hum Genet; 2003 Mar; 112(3):262-71. PubMed ID: 12596051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haplotype analysis at the FRAXA locus in an Indian population.
    Chakraborty SS; Mondal BC; Das S; Das K; Dasgupta UB
    Am J Med Genet A; 2008 Aug; 146A(15):1980-5. PubMed ID: 18627041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile X founder chromosomes in Italy: a few initial events and possible explanation for their heterogeneity.
    Chiurazzi P; Genuardi M; Kozak L; Giovannucci-Uzielli ML; Bussani C; Dagna-Bricarelli F; Grasso M; Perroni L; Sebastio G; Sperandeo MP; Oostra BA; Neri G
    Am J Med Genet; 1996 Jul; 64(1):209-15. PubMed ID: 8826478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype and AGG interspersion analysis of FMR1 alleles in a Croatian population: no founder effect detected in patients with fragile X syndrome.
    Dokić H; Barisić I; Culić V; Lozić B; Hećimović S
    Hum Biol; 2008 Oct; 80(5):581-7. PubMed ID: 19341325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No founder effect detected in Jewish Ashkenazi patients with fragile-X syndrome.
    Pesso R; Barkai G; Ravia Y; Gak E; Frydman M; Goldman B; Friedman E
    Hum Genet; 1997 Dec; 101(2):186-9. PubMed ID: 9402966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of FMR1 and flanking microsatellite markers in normal and fragile X chromosomes in Portugal: evidence for a "protector" haplotype.
    Peixoto A; dos Santos MR; Seruca R; Amorim A; Castedo S
    Eur J Hum Genet; 1998; 6(5):518-22. PubMed ID: 9801877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAXAC1 and DXS548 polymorphisms in the Chinese population.
    Poon PM; Pang CP; Chen QL; Zhong N; Lai KY; Lau CH; Wong CK; Brown WT
    Am J Med Genet; 1999 May; 84(3):208-13. PubMed ID: 10331593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X founder chromosome effects: linkage disequilibrium or microsatellite heterogeneity?
    Zhong N; Ye L; Dobkin C; Brown WT
    Am J Med Genet; 1994 Jul; 51(4):405-11. PubMed ID: 7943008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for high-risk haplotypes and (CGG)n expansion in fragile X syndrome in the Hellenic population of Greece and Cyprus.
    Syrrou M; Patsalis PC; Georgiou I; Hadjimarcou MI; Constantinou-Deltas CD; Pagoulatos G
    Am J Med Genet; 1996 Jul; 64(1):234-8. PubMed ID: 8826482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype.
    Tzeng CC; Tsai LP; Hwu WL; Lin SJ; Chao MC; Jong YJ; Chu SY; Chao WC; Lu CL
    Am J Med Genet A; 2005 Feb; 133A(1):37-43. PubMed ID: 15637705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of (CGG)n and FMR-1 associated microsatellite alleles in a normal Chilean population.
    Jara L; Aspillaga M; Avendaño I; Obreque V; Blanco R; Valenzuela CY
    Am J Med Genet; 1998 Jan; 75(3):277-82. PubMed ID: 9475597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong founder effect for the fragile X syndrome in Sweden.
    Malmgren H; Gustavson KH; Oudet C; Holmgren G; Pettersson U; Dahl N
    Eur J Hum Genet; 1994; 2(2):103-9. PubMed ID: 8044655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype Analysis of DXS548 and FRAXAC1 Microsatellite Loci in Iranian Patients with Fragile X Syndrome.
    Aleyasin SA; Salamat F; Mirakhori M
    Iran J Child Neurol; 2018; 12(1):36-46. PubMed ID: 29379561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype analysis of the fragile X syndrome gene FMR1 in the Czech Republic.
    Pekarík V; Blazková M; Kozák L
    Am J Med Genet; 1999 May; 84(3):214-6. PubMed ID: 10331594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of the fragile X syndrome in Chinese mentally retarded populations is similar to that in Caucasians.
    Zhong N; Ju W; Xu W; Ye L; Shen Y; Wu G; Chen SH; Jin R; Hu XF; Yang A; Liu X; Poon P; Pang C; Zheng Y; Song L; Zhao P; Fu B; Gu H; Brown WT
    Am J Med Genet; 1999 May; 84(3):191-4. PubMed ID: 10331588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fragile X syndrome in Finland: demonstration of a founder effect by analysis of microsatellite haplotypes.
    Haataja R; Väisänen ML; Li M; Ryynänen M; Leisti J
    Hum Genet; 1994 Nov; 94(5):479-83. PubMed ID: 7959680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype.
    Falik-Zaccai TC; Shachak E; Yalon M; Lis Z; Borochowitz Z; Macpherson JN; Nelson DL; Eichler EE
    Am J Hum Genet; 1997 Jan; 60(1):103-12. PubMed ID: 8981953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.